N-[2-(4-ethylphenyl)-1-[5-[4-fluoro-3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-(5-phenyl-1,3,4-oxadiazol-2-yl)ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethynylphenyl)-1-(5-phenyl-1,3,4-oxadiazol-2-yl)ethyl]acetamide;N-[1-(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)hexyl]acetamide

C118H120F7N19O15 — CID 157297519

IUPACN-[2-(4-ethylphenyl)-1-[5-[4-fluoro-3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-(5-phenyl-1,3,4-oxadiazol-2-yl)ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethynylphenyl)-1-(5-phenyl-1,3,4-oxadiazol-2-yl)ethyl]acetamide;N-[1-(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)hexyl]acetamide
SMILESC#Cc1ccc(CC(NC(C)=O)c2nnc(-c3ccccc3)o2)cc1.CCCCCC(NC(C)=O)c1nnc(-c2ccncc2)o1.CCc1ccc(CC(NC(C)=O)c2nnc(-c3ccc(F)c(OC(F)(F)F)c3)o2)cc1.CCc1ccc(CC(NC(C)=O)c2nnc(-c3cccc(OC(F)(F)F)c3)o2)cc1.CCc1ccc(CC(NC(C)=O)c2nnc(-c3cccc(OC)c3)o2)cc1.CCc1ccc(CC(NC(C)=O)c2nnc(-c3ccccc3)o2)cc1
InChIInChI=1S/C21H19F4N3O3.C21H20F3N3O3.C21H23N3O3.C20H21N3O2.C20H17N3O2.C15H20N4O2/c1-3-13-4-6-14(7-5-13)10-17(26-12(2)29)20-28-27-19(30-20)15-8-9-16(22)18(11-15)31-21(23,24)25;1-3-14-7-9-15(10-8-14)11-18(25-13(2)28)20-27-26-19(29-20)16-5-4-6-17(12-16)30-21(22,23)24;1-4-15-8-10-16(11-9-15)12-19(22-14(2)25)21-24-23-20(27-21)17-6-5-7-18(13-17)26-3;2*1-3-15-9-11-16(12-10-15)13-18(21-14(2)24)20-23-22-19(25-20)17-7-5-4-6-8-17;1-3-4-5-6-13(17-11(2)20)15-19-18-14(21-15)12-7-9-16-10-8-12/h4-9,11,17H,3,10H2,1-2H3,(H,26,29);4-10,12,18H,3,11H2,1-2H3,(H,25,28);5-11,13,19H,4,12H2,1-3H3,(H,22,25);4-12,18H,3,13H2,1-2H3,(H,21,24);1,4-12,18H,13H2,2H3,(H,21,24);7-10,13H,3-6H2,1-2H3,(H,17,20)
InChIKeyBBMZSSOLHXCDDF-UHFFFAOYSA-N
MW2177.36 g/mol
LogP22.85
Rot. Bonds39

About N-[2-(4-ethylphenyl)-1-[5-[4-fluoro-3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-(5-phenyl-1,3,4-oxadiazol-2-yl)ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethynylphenyl)-1-(5-phenyl-1,3,4-oxadiazol-2-yl)ethyl]acetamide;N-[1-(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)hexyl]acetamide

N-[2-(4-ethylphenyl)-1-[5-[4-fluoro-3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-(5-phenyl-1,3,4-oxadiazol-2-yl)ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethynylphenyl)-1-(5-phenyl-1,3,4-oxadiazol-2-yl)ethyl]acetamide;N-[1-(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)hexyl]acetamide (PubChem CID 157297519) has the molecular formula C118H120F7N19O15 and a molecular weight of 2177.36 g/mol. Its IUPAC name is N-[2-(4-ethylphenyl)-1-[5-[4-fluoro-3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-(5-phenyl-1,3,4-oxadiazol-2-yl)ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethynylphenyl)-1-(5-phenyl-1,3,4-oxadiazol-2-yl)ethyl]acetamide;N-[1-(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)hexyl]acetamide.

Molecular Properties

Compound NameN-[2-(4-ethylphenyl)-1-[5-[4-fluoro-3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-(5-phenyl-1,3,4-oxadiazol-2-yl)ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethynylphenyl)-1-(5-phenyl-1,3,4-oxadiazol-2-yl)ethyl]acetamide;N-[1-(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)hexyl]acetamide
PubChem CID157297519
Molecular FormulaC118H120F7N19O15
Molecular Weight2177.36 g/mol
Exact Mass2175.91
IUPAC NameN-[2-(4-ethylphenyl)-1-[5-[4-fluoro-3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-(5-phenyl-1,3,4-oxadiazol-2-yl)ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethynylphenyl)-1-(5-phenyl-1,3,4-oxadiazol-2-yl)ethyl]acetamide;N-[1-(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)hexyl]acetamide
SMILESC#Cc1ccc(CC(NC(C)=O)c2nnc(-c3ccccc3)o2)cc1.CCCCCC(NC(C)=O)c1nnc(-c2ccncc2)o1.CCc1ccc(CC(NC(C)=O)c2nnc(-c3ccc(F)c(OC(F)(F)F)c3)o2)cc1.CCc1ccc(CC(NC(C)=O)c2nnc(-c3cccc(OC(F)(F)F)c3)o2)cc1.CCc1ccc(CC(NC(C)=O)c2nnc(-c3cccc(OC)c3)o2)cc1.CCc1ccc(CC(NC(C)=O)c2nnc(-c3ccccc3)o2)cc1
InChIInChI=1S/C21H19F4N3O3.C21H20F3N3O3.C21H23N3O3.C20H21N3O2.C20H17N3O2.C15H20N4O2/c1-3-13-4-6-14(7-5-13)10-17(26-12(2)29)20-28-27-19(30-20)15-8-9-16(22)18(11-15)31-21(23,24)25;1-3-14-7-9-15(10-8-14)11-18(25-13(2)28)20-27-26-19(29-20)16-5-4-6-17(12-16)30-21(22,23)24;1-4-15-8-10-16(11-9-15)12-19(22-14(2)25)21-24-23-20(27-21)17-6-5-7-18(13-17)26-3;2*1-3-15-9-11-16(12-10-15)13-18(21-14(2)24)20-23-22-19(25-20)17-7-5-4-6-8-17;1-3-4-5-6-13(17-11(2)20)15-19-18-14(21-15)12-7-9-16-10-8-12/h4-9,11,17H,3,10H2,1-2H3,(H,26,29);4-10,12,18H,3,11H2,1-2H3,(H,25,28);5-11,13,19H,4,12H2,1-3H3,(H,22,25);4-12,18H,3,13H2,1-2H3,(H,21,24);1,4-12,18H,13H2,2H3,(H,21,24);7-10,13H,3-6H2,1-2H3,(H,17,20)
InChIKeyBBMZSSOLHXCDDF-UHFFFAOYSA-N
XLogP22.85
TPSA448.70 Ų
H-Bond Donors6
H-Bond Acceptors28
Rotatable Bonds39
Heavy Atoms159
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002177.36
LogP ≤ 522.85
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1028

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze N-[2-(4-ethylphenyl)-1-[5-[4-fluoro-3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-(5-phenyl-1,3,4-oxadiazol-2-yl)ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethynylphenyl)-1-(5-phenyl-1,3,4-oxadiazol-2-yl)ethyl]acetamide;N-[1-(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)hexyl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[2-(4-ethylphenyl)-1-[5-[4-fluoro-3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-(5-phenyl-1,3,4-oxadiazol-2-yl)ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethynylphenyl)-1-(5-phenyl-1,3,4-oxadiazol-2-yl)ethyl]acetamide;N-[1-(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)hexyl]acetamide?
The IUPAC name of N-[2-(4-ethylphenyl)-1-[5-[4-fluoro-3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-(5-phenyl-1,3,4-oxadiazol-2-yl)ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethynylphenyl)-1-(5-phenyl-1,3,4-oxadiazol-2-yl)ethyl]acetamide;N-[1-(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)hexyl]acetamide (CID 157297519) is N-[2-(4-ethylphenyl)-1-[5-[4-fluoro-3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-(5-phenyl-1,3,4-oxadiazol-2-yl)ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethynylphenyl)-1-(5-phenyl-1,3,4-oxadiazol-2-yl)ethyl]acetamide;N-[1-(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)hexyl]acetamide.
What is the SMILES notation for N-[2-(4-ethylphenyl)-1-[5-[4-fluoro-3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-(5-phenyl-1,3,4-oxadiazol-2-yl)ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethynylphenyl)-1-(5-phenyl-1,3,4-oxadiazol-2-yl)ethyl]acetamide;N-[1-(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)hexyl]acetamide?
The canonical SMILES for N-[2-(4-ethylphenyl)-1-[5-[4-fluoro-3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-(5-phenyl-1,3,4-oxadiazol-2-yl)ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethynylphenyl)-1-(5-phenyl-1,3,4-oxadiazol-2-yl)ethyl]acetamide;N-[1-(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)hexyl]acetamide is C#Cc1ccc(CC(NC(C)=O)c2nnc(-c3ccccc3)o2)cc1.CCCCCC(NC(C)=O)c1nnc(-c2ccncc2)o1.CCc1ccc(CC(NC(C)=O)c2nnc(-c3ccc(F)c(OC(F)(F)F)c3)o2)cc1.CCc1ccc(CC(NC(C)=O)c2nnc(-c3cccc(OC(F)(F)F)c3)o2)cc1.CCc1ccc(CC(NC(C)=O)c2nnc(-c3cccc(OC)c3)o2)cc1.CCc1ccc(CC(NC(C)=O)c2nnc(-c3ccccc3)o2)cc1.
What is the InChIKey of N-[2-(4-ethylphenyl)-1-[5-[4-fluoro-3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-(5-phenyl-1,3,4-oxadiazol-2-yl)ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethynylphenyl)-1-(5-phenyl-1,3,4-oxadiazol-2-yl)ethyl]acetamide;N-[1-(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)hexyl]acetamide?
The InChIKey is BBMZSSOLHXCDDF-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H19F4N3O3.C21H20F3N3O3.C21H23N3O3.C20H21N3O2.C20H17N3O2.C15H20N4O2/c1-3-13-4-6-14(7-5-13)10-17(26-12(2)29)20-28-27-19(30-20)15-8-9-16(22)18(11-15)31-21(23,24)25;1-3-14-7-9-15(10-8-14)11-18(25-13(2)28)20-27-26-19(29-20)16-5-4-6-17(12-16)30-21(22,23)24;1-4-15-8-10-16(11-9-15)12-19(22-14(2)25)21-24-23-20(27-21)17-6-5-7-18(13-17)26-3;2*1-3-15-9-11-16(12-10-15)13-18(21-14(2)24)20-23-22-19(25-20)17-7-5-4-6-8-17;1-3-4-5-6-13(17-11(2)20)15-19-18-14(21-15)12-7-9-16-10-8-12/h4-9,11,17H,3,10H2,1-2H3,(H,26,29);4-10,12,18H,3,11H2,1-2H3,(H,25,28);5-11,13,19H,4,12H2,1-3H3,(H,22,25);4-12,18H,3,13H2,1-2H3,(H,21,24);1,4-12,18H,13H2,2H3,(H,21,24);7-10,13H,3-6H2,1-2H3,(H,17,20).
What are the key properties of N-[2-(4-ethylphenyl)-1-[5-[4-fluoro-3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-(5-phenyl-1,3,4-oxadiazol-2-yl)ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethynylphenyl)-1-(5-phenyl-1,3,4-oxadiazol-2-yl)ethyl]acetamide;N-[1-(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)hexyl]acetamide?
N-[2-(4-ethylphenyl)-1-[5-[4-fluoro-3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-(5-phenyl-1,3,4-oxadiazol-2-yl)ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethynylphenyl)-1-(5-phenyl-1,3,4-oxadiazol-2-yl)ethyl]acetamide;N-[1-(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)hexyl]acetamide has a molecular weight of 2177.36 g/mol, XLogP of 22.85, 39 rotatable bonds, 6 hydrogen bond donors, and 28 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-(4-ethylphenyl)-1-[5-[4-fluoro-3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-(5-phenyl-1,3,4-oxadiazol-2-yl)ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethynylphenyl)-1-(5-phenyl-1,3,4-oxadiazol-2-yl)ethyl]acetamide;N-[1-(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)hexyl]acetamide is sourced from PubChem (CID 157297519), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).